Morgan H James
Morgan H James
Dept of Psychiatry and Brain Health Institute, Rutgers University, NJ, USA
Verified email at uon.edu.au - Homepage
Title
Cited by
Cited by
Year
Motivational activation: a unifying hypothesis of orexin/hypocretin function
SV Mahler, DE Moorman, RJ Smith, MH James, G Aston-Jones
Nature Neuroscience 17 (10), 1298-1303, 2014
2272014
Differential roles of medial prefrontal subregions in the regulation of drug seeking
DE Moorman, MH James, EM McGlinchey, G Aston-Jones
Brain research 1628, 130-146, 2015
1422015
Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking
MH James, JL Charnley, EM Levi, E Jones, JW Yeoh, DW Smith, ...
International Journal of Neuropsychopharmacology 14 (5), 684-690, 2011
1182011
Cocaine-and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour
MH James, JL Charnley, E Jones, EM Levi, JW Yeoh, JR Flynn, DW Smith, ...
PLoS One 5 (9), e12980, 2010
882010
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
JW Yeoh, EJ Campbell, MH James, BA Graham, CV Dayas
Frontiers in neuroscience 8, 36, 2014
822014
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
MH James, SV Mahler, DE Moorman, G Aston-Jones
Behavioral Neuroscience of Orexin/Hypocretin, 247-281, 2017
792017
Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking
EM McGlinchey, MH James, SV Mahler, C Pantazis, G Aston-Jones
Journal of Neuroscience 36 (33), 8700-8711, 2016
712016
Propensity to ‘relapse’following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei
MH James, JL Charnley, JR Flynn, DW Smith, CV Dayas
Neuroscience 199, 235-242, 2011
662011
Role of the orexin/hypocretin system in stress-related psychiatric disorders
MH James, EJ Campbell, CV Dayas
Behavioral Neuroscience of Orexin/Hypocretin, 197-219, 2017
592017
Increased number and activity of a lateral subpopulation of hypothalamic orexin/hypocretin neurons underlies the expression of an addicted state in rats
MH James, CM Stopper, BA Zimmer, NE Koll, HE Bowrey, G Aston-Jones
Biological psychiatry 85 (11), 925-935, 2019
522019
Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats
MH James, EJ Campbell, FR Walker, DW Smith, HN Richardson, ...
Frontiers in behavioral neuroscience 8, 244, 2014
482014
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
DE Moorman, MH James, EA Kilroy, G Aston-Jones
Brain Research 1654, 34-42, 2017
452017
Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner
DE Moorman, MH James, EA Kilroy, G Aston‐Jones
European Journal of Neuroscience 43 (5), 710-720, 2016
452016
What about me...? The PVT: A role for the paraventricular thalamus (PVT) in drug-seeking behaviour.
MH James, CV Dayas
Frontiers in Behavioral Neuroscience 7, 18, 2013
412013
Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus
JW Yeoh, MH James, P Jobling, JS Bains, BA Graham, CV Dayas
The Journal of Physiology 590 (16), 3677-3689, 2012
392012
Insights for developing pharmacological treatments for psychostimulant relapse targeting hypothalamic peptide systems
MH James, JW Yeoh, BA Graham, CV Dayas
Journal of Addiction Research & Therapy, 2012
362012
mTORC1 Inhibition in the Nucleus Accumbens ‘Protects’ Against the Expression of Drug Seeking and ‘Relapse’and Is Associated with Reductions in GluA1 AMPAR and CAMKIIα Levels
MH James, RK Quinn, LK Ong, EM Levi, JL Charnley, DW Smith, ...
Neuropsychopharmacology 39 (7), 1694-1702, 2014
302014
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin‐1 receptor antagonist in rats
MH James, HE Bowrey, CM Stopper, G Aston‐Jones
European Journal of Neuroscience 50 (3), 2602-2612, 2019
262019
Rapamycin reduces motivated responding for cocaine and alters GluA1 expression in the ventral but not dorsal striatum
MH James, RK Quinn, LK Ong, EM Levi, DW Smith, PW Dickson, ...
European journal of pharmacology 784, 147-154, 2016
212016
The role of orexin-1 receptor signaling in demand for the opioid fentanyl.
JE Fragale, CB Pantazis, MH James, G Aston-Jones
Neuropsychopharmacology 44 (10), 1690-1697, 2019
202019
The system can't perform the operation now. Try again later.
Articles 1–20